Modulating myocardial metabolism in preclinical hypertrophic cardiomyopathy (HCM) pathogenic variant carriers: a window of opportunity or wishful thinking?

IF 13.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Research Pub Date : 2025-09-05 DOI:10.1093/cvr/cvaf157

Betty Raman,Emil Brociek

引用次数: 0

查看原文本刊更多论文

调节临床前肥厚性心肌病（HCM）致病变异携带者的心肌代谢：机会之窗还是一厢情愿？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Research 医学-心血管系统

CiteScore

21.50

自引率

3.70%

发文量

547

审稿时长

1 months

期刊介绍： Cardiovascular Research Journal Overview: International journal of the European Society of Cardiology Focuses on basic and translational research in cardiology and cardiovascular biology Aims to enhance insight into cardiovascular disease mechanisms and innovation prospects Submission Criteria: Welcomes papers covering molecular, sub-cellular, cellular, organ, and organism levels Accepts clinical proof-of-concept and translational studies Manuscripts expected to provide significant contribution to cardiovascular biology and diseases